Analysis of the p16(INK4A), p15(INK4B) and p18(INK4C) genes in multiple myeloma

British Journal of Haematology

Volumn 96, Issue 1, 1997, Pages 98-102

  Tasaka, Taizo ^a   Berenson, James ^a   Vescio, Robert ^a   Hirama, Toshiyasu ^a   Miller, Carl W ^a   Nagai, Masami ^b   Takahara, Jiro ^b   Koeffler, H Phillip ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

cell cycle; cyclin dependent kinase inhibitor; multiple myeloma; plasma cell leukaemia; tumour suppressor gene

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P15; PROTEIN P16; PROTEIN P18; UNCLASSIFIED DRUG; CARRIER PROTEIN; CDKN2C PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 2C; ENZYME INHIBITOR; PROTEIN P16INK4A; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MULTIPLE MYELOMA; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; GENE DELETION; GENETICS; MIDDLE AGED; POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; SOUTHERN BLOTTING;

ADULT; AGED; BLOTTING, SOUTHERN; CARRIER PROTEINS; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P18; CYCLIN-DEPENDENT KINASES; ENZYME INHIBITORS; FEMALE; GENE DELETION; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TUMOR SUPPRESSOR PROTEINS;

EID: 0030614848     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.8552482.x     Document Type: Article

References (29)

1. Ankathil, R., Madhavan, J., Gangadharan, V.P., Pillai. G.R. & Nair, M.K. (1995) Non-random karyotype abnormalities in 56 multiple myeloma patients. Cancer Genetics and Cytogenetics, 83, 71-74.
2. Cigudosa, J.C., Calasanz, M.J., Odero, M.D., Prosper, F., Etxaniz, A., Marin, J., Rifon, J., Gullon, A. & Rocha, K. (1994) Cytogenetic data in 41 patients with multiple myeloma: karyotype and other clinical parameters. Cancer Genetics and Cytogenetics, 78, 210-215.
3. Glendening, J.M., Flores, J.F., Walker, G.J., Stone, S., Albino, A.P. & Fountain, J.W. (1995) Homozygous loss of the p15INK4B gene (and not the p16INK4 gene) during tumor progression in a sporadic melanoma patient. Cancer Research, 55, 5531-5535.
4. Gombart, A.F., Morosetti, R., Miller, C.W., Said, J.W. & Koeffler, H.P. (1995) Deletions of the cyclin-dependent kinase inhibitor genes p16INK4A and p15INK4B in non-Hodgkin's lymphomas. Blood, 86, 1534-1539.
5. Gonzalez-Zulueta, M., Bender, C.M., Yang, A.S., Nguyen, T., Beart, R.W., Van Tornout, J.M. & Jones, P.A. (1995) Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Research, 55, 4531-4535.
6. INK4B/MTS2 - related CDK6 inhibitor, correlates with wild-type pRb function. Genes and Development, 8, 2939-2952.
7. INK4B is a potential effecter of TGF-b-induced cell cycle arrest. Nature, 371, 257-261.
8. Hatta, Y., Hirama, T., Miller, C.W., Yamada, Y., Tomonaga, M. & Koeffler, H.P. (1995) Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia. Blood, 85, 2699-2704.
9. INK4B) display frequent homozygous deletions in primary cells from T-but not from B-cell lineage acute lymphoblastic leukemias. Blood, 84, 4038-4044.
10. INK4BI. Cancer Research, 56, 722-727.
11. Herman, J.G., Merlo, A., Mao, L., Lapidus, R.G., Issa, J.P., Davidson, N.E., Sidransky, D. & Baylin, S.B. (1995) Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Research, 55, 4525-4530.
12. Hirama, T, & Koeffler, H.P. (1995) Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood, 86, 841-854.
13. Hunter, T. & Pines, J. (1994) Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age. Cell, 79, 573-582.
14. Koh, J., Enders, G.H., Dynlacht, B.D. & Harlow, E. (1995) Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature, 375, 506-510.
15. Lai, J.L., Zandecki, M., Mary, J.Y., Bernardi, F., Izydorczyk, V., Flactif, M., Morel, P., Jouet, J.P., Bauters, F. & Facon, T. (1995) Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis. Blood, 85, 2490-2497.
16. Lukas, J., Parry, D., Aagaard, L., Mann, D.J., Bartkova, J., Strauss, M., Peters, G. & Bartek, J. (1995) Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature, 75, 503-506.
17. Nakamaki, T., Kawamata, N., Schwaller, J., Tobler, A., Fey, M., Pakkala, S., Lee, Y.Y., Kim, B.K., Fukuchi, K., Tsuruoka, N., Kahan, J., Miller, C.W. & Koeffler, H.P. (1995) Structural integrity of the cyclin-dependent kinase inhibitor genes, p15 p16 and p18 in myeloid leukacmias. British Journal of Haematology, 91, 139-149.
18. Nigro, J.M., Baker, S.J., Preisinger, A.C., Jessup, J.M., Hostetter, R., Cleary, K., Bigner, S.H., Davidson, N., Baylin, S., Devilee, P., Glover, T., Collins, F.S., Weston, A., Modali, R., Harris, C.C. & Vogelstein, B. (1989) Mutations in p53 gene occur in diverse human tumour types. Nature, 342, 705-708.
19. Ogawa, S., Hangaishi, A., Miyawaki, S., Hirosawa, S., Miura, Y., Takeyama, K., Kamada, N., Ohtake, S., Uike, N., Shimazaki, C., Toyama, K., Hirano, M., Mizoguchi, H., Kobayushi, Y., Furusawa, S., Saito, M., Emi, N., Yazaki, Y. & Hirai, H. (1995) Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies. Blood, 86, 1548-1556.
20. Okamoto, A., Hussain, S., Hagiwara, K., Spillare, H.A., Rusin, M.R., Demetrick, U.J., Serrano, M., Hannon, G.J., Shiseki, M., Zariwala, M., Xiong, Y., Beach, D., Yokota, J. & Harris, C.C. (1995) Mutations in the p16INK4/MTS1/CDKN2, p15INK4B/MTS2, and p 18 genes in primary and metastatic lung cancer. Cancer Research, 55, 1448-1451.
21. Quesnel, B., Preudhomme, C., Philippe, N., Vanrumbcke, M., Dervite, I., Lai, J.L., Bauters, F., Wattel, E. & Fenaux, P. (1995) p16 gene homozygous deletions in acute lymphoblastic leukemia. Blood, 85, 657-663.
22. Sherr, C.J. (1995) Mammalian G1 cyclins. Cell, 73, 1059-1065.
23. Serrano, M., Hannon, G.J. & Beach, D. (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK 4. Nature, 366, 704-707.
24. Shapiro, G.I., Park, J.K., Edwards, C.D., Mao, L., Merlo, A., Sidransky, D., Ewen, M.E. & Rollins, B.J. (1995) Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines. Cancer Research, 55, 6200-6209.
25. Stranks, G., Height, S.E., Mitchell, P., Jadayel, D., Yuille, M.A., De Lord, C., Clutterbuck, R.D., Treleaven, J.G., Powles, R.L. & Nacheva, E. (1995) Deletions and rearrangement of CDKN2 in lymphoid malignancy. Blood, 85, 893-901.
26. Takeuchi, S., Bartram, C.R., Seriu, T., Miller, C.W., Tobler, A., Janssen, J.W., Reiter, A., Ludwig, W.D., Zimmermann, M., Schwaller, J., Lee, E., Miyoshi, I. & Koeffler, H.P. (1995) Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/ 1NK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood. Blood, 86, 755-760.
27. Taniwaki, M., Nishida, K., Takashima, T., Nakagawa, H., Fujii, H., Tamaki, T., Shimazaki, C., Horiike, S., Misawa, S., Abe, T. & Kashima, K. (1994) Non-random chromosomal rearrangements of 14q32.3 and 19p13.3 and preferential deletion of 1p in 21 patients with multiple myeloma and plasma cell leukemia. Blood, 84, 2283-2290.
28. Weh, H.J., Gutensohn, K., Selbach, J., Kruse, R., Wacker-Backhaus, G., Seeger, D., Fiedler, W., Fett, W. & Hossfeld, D.K. (1993) Karyotype in multiple myeloma and plasma cell leukaemia. European Journal of Cancer, 29, 1269-1273.
29. Yang, R., Gombart, A.F., Serrano, M. & Koefller, H.P. (1995) Mutational effects on the p16INK4a tumor suppressor protein. Cancer Research, 55, 2503-2506.